Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.6.4 replaces the previous Revision: v3.6.3 on the page. This appears to be a backend/UI update and does not modify study data or visible page content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a small site update. The study details and other content remain unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of v3.6.0, indicating a minor update to the page template. This update does not affect the study details or the information presented to users.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page adds new help/navigation items (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision tag to v3.6.0, while the previous label 'Intervention / Treatment' was removed and replaced with 'Intervention/Treatment'.SummaryDifference0.5%

- Check61 days agoChange DetectedThe revision tag in the page footer was updated from v3.5.4 to v3.5.5, indicating a minor software update to the page.SummaryDifference0.1%

- Check82 days agoChange DetectedA clinical study report synopsis, sponsor-related items (AbbVie), and a new 'Helpful Links Provided by AbbVie' section were added, and the page revision was updated to v3.5.4.SummaryDifference0.2%

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.